It is not only highly mutated and overexpressed in tumor patients but also promotes the proliferation and metastasis of PCa through various mechanisms, including activation of the leukemia inhibitory factor receptor (LIFR), Kruppel-like factor-4 (KLF4) and antioxidant pathways [15–17]. The gene discussed is LIFR; the disease is neoplasm.